Comparison of pulmonary thin section CT findings and serum KL-6 levels in patients with sarcoidosis

British Journal of Radiology

Volumn 84, Issue 999, 2011, Pages 229-235

  Honda, K ^a   Okada, Fumito ^a   Ando, Y ^a   Mori, H ^a   Umeki, K ^a   Ishii, H ^a   Kadota, J ^a   Ando, M ^a   Miyazaki, E ^a   Kumamoto, T ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOPROTEIN KL 6; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LABORATORY TEST; LUNG BIOPSY; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SARCOIDOSIS; SERUM; THORAX RADIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; LUNG; LYMPH NODES; MALE; MICROTOMY; MIDDLE AGED; MUCIN-1; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79951918097     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/65287605     Document Type: Article

References (31)

1. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity: sialylated carbohydrate antigen KL-6. Chest 1989;96:68-73. (Pubitemid 19176416)
2. Kobayashi J, Kitamura S. KL-6: A serum marker for interstitial pneumonia. Chest 1995;108:311-15.
3. Ogawa Y, Ishikawa T, Ikeda K, Nakata B, Sawada T, Ogisawa K, et al. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer. Clin Cancer Res 2000;6:4069-72.
4. Kohno N, Inoue Y, Hamada H, Fujioka S, Fujino S, Yokoyama A, et al. Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9. Int J Cancer 1994;8 (Suppl):81-3. (Pubitemid 24188964)
5. Takahashi T, Takamura K, Sakaue S, Ishii J, Yokouchi H, Nasuhara Y. Elevated serum KL-6 concentrations in patients with diabetes mellitus. J Diabetes Complications 2002;16:352-8.
6. Kohno N, Akiyama M, Kyoizumi S, Hakoda M, Kobuke K, Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988;18:203-16.
7. Kohno N, Awaya Y, Oyama T, Yamakido M, Akiyama M, Inoue Y, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993;148:637-42. (Pubitemid 23263772)
8. Ishii H, Mukae H, Kadota J, Kaida H, Nagata T, Abe K, et al. High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia. Thorax 2003;58:52-7. (Pubitemid 36135359)
9. Okada F, Ando Y, Honda K, Tanoue S, Matsumoto S, Mori H. Comparison of pulmonary CT findings and serum KL-6 levels in patients with cryptogenic organizing pneumonia. Br J Radiol 2009;82:212-18.
10. Yokoyama A, Kondo K, Nakajima M, Matsushima T, Takahashi T, Nishimura M, et al. Prognostic value of circulation KL-6 in idiopathic pulmonary fibrosis. Respirology 2006;11:164-8. (Pubitemid 43356896)
11. Lin FC, Chen YC, Chang SC. Clinical importance of bronchoalveolar lavage fluid and blood cytokines, surfactant protein D, and Kerbs von Lungren 6 antigen in idiopathic pulmonary alveolar proteinosis. Myyo Clin Proc 2008;83:1344-9.
12. Hant FN, Ludwicka-Bradley A, Wang HJ, Li N, Elashoff R, Tashkin DP, et al. Scleroderma Lung Study Research Group. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol 2009;36:773-80.
13. Satoh H, Kurishima K, Ishikawa H, Ohtsuka M. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J Intern Med 2006;260:429-34. (Pubitemid 44571130)
14. Kitaichi N, Ariga T, Kase S, Yoshida K, Namba K, Ohno S. Usefulness of quantifying serum KL-6 levels in the followup of uveitic patients with sarcoidosis. Graefes Arch Clin Exp Ophthalol 2006;244:433-7.
15. Janssen R, Sato H, Glutters JC, Bernard A, van Velzen-Blad H, du Bois RM, et al. Study of Clara cell 16, KL-6, and surfactant protein-D in serum as disease markers in pulmonary sarcoidosis. Chest 2003;124:2119-25.
16. Kobayashi J, Kitamura S. Serum KL-6 for the evaluation of active pneumonitis in pulmonary sarcoidosis. Chest 1996;109:1276-82. (Pubitemid 26145667)
17. Statement on sarcoidosis: joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
18. Webb WR, Muller NL, Naidich DP. High-resolution computed tomography findings of lung disease. In: Aughenbaugh GL, ed. High-resolution CT of the lung, 3rd edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2001: 71-192.
19. Austin JH, Muller NL, Friedman PJ, Hansell DM, Naidich DP, Remy-Jardin M, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996;200:327-31. (Pubitemid 26249879)
20. Inoue Y, Barker E, Daniloff E, Hohno N, Hiwada K, Newman S. Pulmonary epithelial cell injury and alveolarcapillary permeability in berylliosis. Am J Respir Crit Care Med 1997;156:109-15. (Pubitemid 27293174)
21. Hirasawa Y, Kohno N, Yokoyama A, Inoue Y, Abe M, Hiwada K. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997;17:501-7. (Pubitemid 127500983)
22. Foley NM, Coral AP, Tung K, Hudspith BN, James DG, Johnson NM. Bronchoalveolar lavage cell counts as a predictor of short outcome in pulmonary sarcoidosis. Thorax 1989;44:732-8. (Pubitemid 19243271)
23. Maycock RL, Bertrand P, Morrison CE, Scott JH. Manifestation of sarcoidosis: analysis of 145 patients, with a review of nine series selected from the literature. Am J Med 1963;35:67-89.
24. Israel HL. Prognosis of sarcoidosis. Ann Intern Med 1970;73:1038-9.
25. Hiroshige S, Ando M,Okubo F, Ueno T, Fukami T, Takenaka R, et al. A case of pulmonary sarcoidosis demonstration Panlobular ground-glass opacity with mosaic distribution. Nihon Kokyuki Gakkai Zasshi 2009;47:212-17.
26. Remy-Jardin M, Giraud F, Remy J, Copin MC, Gosselin B, Duhamel A. Importance of ground-glass attenuation in chronic diffuse infiltrative lung disease: pathologic-CT correlation. Radiology 1993;189:693-8. (Pubitemid 23354479)
27. Lynch DA, Webb WR, Gamsu G, Stubarg M, Golden J. Computed tomography in pulmonary sarcoidosis. J Comput Assist Tomogr 1989;13:405-10. (Pubitemid 19141757)
28. Westcott JL, Cole SR. Traction bronchiectasis in end-stage pulmonary fibrosis. Radiology 1986;161:665-9. (Pubitemid 17200414)
29. Nishimura K, Itoh H, Kitaichi M, Nagai S, Izumi T. Pulmonary sarcoidosis: correlation of CT and histopathologic findings. Radiology 1993;189:105-9. (Pubitemid 23292931)
30. Nakano Y, Kurihara N, Miyamoto O, Takamatus K, Adachi N, Fujiwara H, et al. A case of sarcoidosis beginning with extensive ground-glass pattern on chest X-ray, accompanied with high fever and eosinophilia. Nihon Kyobu Shikkan Gakkai Zasshi 1989;27:98-106. (Pubitemid 19068924)
31. Abehsera M, Veleyre D, Grenier P, Jaillet H, Battesti JP, Brauner MW. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 2000;174:1751-7. (Pubitemid 30346752)